Manulife (Manufacturers Life Insurance)
PRME icon

Manulife (Manufacturers Life Insurance)’s Prime Medicine PRME Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$100K Sell
28,872
-2,730
-9% -$10.4K ﹤0.01% 2626
2025
Q4 		$110K Buy
31,602
+4,470
+16% +$19.9K ﹤0.01% 2686
2025
Q3 		$150K Buy
27,132
+6,153
+29% +$25K ﹤0.01% 2673
2025
Q2 		$51.8K Sell
20,979
-3,945
-16% -$6.08K ﹤0.01% 2884
2025
Q1 		$49.6K Buy
24,924
+1,332
+6% +$3.4K ﹤0.01% 2834
2024
Q4 		$68.9K Buy
23,592
+197
+0.8% +$692 ﹤0.01% 2888
2024
Q3 		$90.5K Sell
23,395
-743
-3% -$3.44K ﹤0.01% 2887
2024
Q2 		$124K Sell
24,138
-50,790
-68% -$308K ﹤0.01% 2769
2024
Q1 		$524K Buy
74,928
+10,381
+16% +$78.7K ﹤0.01% 2193
2023
Q4 		$572K Sell
64,547
-113
-0.2% -$871 ﹤0.01% 2120
2023
Q3 		$617K Buy
64,660
+6,259
+11% +$81.3K ﹤0.01% 2028
2023
Q2 		$856K Buy
58,401
+12,770
+28% +$178K ﹤0.01% 1742
2023
Q1 		$561K Buy
45,631
+642
+1% +$10.5K ﹤0.01% 1939
2022
Q4 		$887K Buy
+44,989
New +$813K ﹤0.01% 1670

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s PRME Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Prime Medicine (PRME) stake by 8.6% in Q1 2026, selling an estimated $10.4K and leaving 28,872 shares worth $100K. The position accounts for ﹤0.01% of the portfolio, ranked #2626.

Manulife (Manufacturers Life Insurance) first reported a position in PRME in Q4 2022 and has held it in 14 quarters since. The position peaked at $887K in Q4 2022. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 28,872 shares of Prime Medicine worth $100K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 2,730 Prime Medicine shares in Q1 2026, an estimated $10.4K.
  • Prime Medicine made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2626 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Prime Medicine in Q4 2022 and has held it in 14 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Prime Medicine position peaked at $887K in Q4 2022.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.